U.S. flag

An official website of the United States government

NM_000059.4(BRCA2):c.7069_7070del (p.Leu2357fs) AND BRCA2-related disorder

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 12, 2023
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004541046.2

Allele description [Variation Report for NM_000059.4(BRCA2):c.7069_7070del (p.Leu2357fs)]

NM_000059.4(BRCA2):c.7069_7070del (p.Leu2357fs)

Gene:
BRCA2:BRCA2 DNA repair associated [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
13q13.1
Genomic location:
Preferred name:
NM_000059.4(BRCA2):c.7069_7070del (p.Leu2357fs)
Other names:
2357delCT; 7297_7298delCT
HGVS:
  • NC_000013.10:g.32929058_32929059del
  • NC_000013.11:g.32354922_32354923del
  • NG_012772.3:g.44443_44444del
  • NM_000059.4:c.7069_7070delMANE SELECT
  • NP_000050.3:p.Leu2357fs
  • LRG_293:g.44443_44444del
  • NC_000013.10:g.32929058_32929059del
  • NC_000013.10:g.32929059_32929060del
  • NC_000013.10:g.32929059_32929060del
  • NC_000013.10:g.32929059_32929060delCT
  • NM_000059.3:c.7069_7070delCT
  • NM_000059.4:c.7069_7070del
  • NM_000059.4:c.7069_7070delCT
  • U43746.1:n.7297_7298delCT
  • p.L2357VFS*2
  • p.L2357VfsX2
  • p.Leu2357Valfs*2
  • p.Leu2357ValfsX2
  • p.Leu2357fs
Nucleotide change:
7297delCT
Links:
Breast Cancer Information Core (BIC) (BRCA2): 7297&base_change=del CT; dbSNP: rs80359636
NCBI 1000 Genomes Browser:
rs80359636
Molecular consequence:
  • NM_000059.4:c.7069_7070del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
BRCA2-related disorder
Synonyms:
BRCA2-Related Disorders; BRCA2-related condition
Identifiers:
MedGen: CN239275

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004762720PreventionGenetics, part of Exact Sciences
no assertion criteria provided
Pathogenic
(Dec 12, 2023)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From PreventionGenetics, part of Exact Sciences, SCV004762720.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The BRCA2 c.7069_7070delCT variant is predicted to result in a frameshift and premature protein termination (p.Leu2357Valfs*2). This variant has been reported to be causative for hereditary cancer such as breast, ovarian, or colorectal cancers (reported as 7297delCT in Garvin et al. 1997. PubMed ID: 9429140; eTable 3, Pearlman et al. 2017. PubMed ID: 27978560; Table S3, Labidi-Galy et al. 2018. PubMed ID: 29084914; Heramb et al. 2018. PubMed ID: 29339979). This variant is reported in 0.0054% of alleles in individuals of European (Non-Finnish) descent in gnomAD and is interpreted as pathogenic in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/38082/). Frameshift variants in BRCA2 are expected to be pathogenic. This variant is interpreted as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024